Axsome Therapeutics

Companies to Watch: 12 Late-Stage Contenders in Neurodegenerative Disease
Companies to Watch: 12 Late-Stage Contenders in Neurodegenerative Disease
BioSpace
neurodegenerative disease
Alzheimer's disease
Axsome Therapeutics
Eli Lilly
Anavex
TauRx
AB Science
ALS
BrainStorm Cell Therapeutics
Seelos Therapeutics
Parkinson's Disease
AbbVie
Mitsubishi Tanabe Pharma
Annovis
Huntington's disease
Prilenia Therapeutics
Neurocrine
Flag link:
Where Will Axsome Therapeutics Be in 3 Years?
Where Will Axsome Therapeutics Be in 3 Years?
Motley Fool
Axsome Therapeutics
Sunosi
Auvelity
Flag link:
Biotech heads towards big catalysts
Biotech heads towards big catalysts
EP Vantage
biotech
clinical trials
Alnylam Pharmaceuticals
Arcus Biosciences
Argenx
Arrowhead Pharmaceuticals
Axsome Therapeutics
Bavarian Nordic
FibroGen
Gilead Sciences
Incyte
Morphic Therapeutic
PTC Therapeutics
Syndax Pharmaceuticals
Travere Therapeutics
Vaxcyte
Flag link:
Axsome says FDA wants more data for Alzheimer’s agitation label expansion, but readout to come sooner 
Axsome says FDA wants more data for Alzheimer’s agitation label expansion, but readout to come sooner 
Endpoints
Axsome Therapeutics
FDA
clinical trials
Alzheimer's disease agitation
Alzheimer's disease
AXS-05
Flag link:
Axsome Headed to FDA after Phase III Alzheimer's Agitation Win
Axsome Headed to FDA after Phase III Alzheimer's Agitation Win
BioSpace
Axsome Therapeutics
clinical trials
Alzheimer's disease
Alzheimer's agitation
AXS-05
Flag link:
3 Biopharmas on Buyout Watch
3 Biopharmas on Buyout Watch
Motley Fool
M&A
Axsome Therapeutics
Alnylam Pharmaceuticals
Karuna Therapeutics
Flag link:
Axsome's depression drug enters competitive market after U.S. approval
Axsome's depression drug enters competitive market after U.S. approval
Reuters
Axsome Therapeutics
clinical depression
FDA
Auvelity
Flag link:
As expected, FDA spikes down Axsome migraine med, but issues are 'addressable'
As expected, FDA spikes down Axsome migraine med, but issues are 'addressable'
Fierce Biotech
Axsome Therapeutics
migraines
FDA
AXS-07
Flag link:
It's CRL Day at the FDA as Axsome, Junshi and Coherus Get Bad News
It's CRL Day at the FDA as Axsome, Junshi and Coherus Get Bad News
BioSpace
FDA
complete response letter
Junshi Biosciences
Coherus Biosciences
Axsome Therapeutics
migraines
AXS-07
Flag link:
Axsome expects migraine drug to be rejected as manufacturing issues arise
Axsome expects migraine drug to be rejected as manufacturing issues arise
Endpoints
Axsome Therapeutics
migraines
FDA
AXS-07
Flag link:
The FDA Will Soon Give These 3 Healthcare Companies the Green Light
The FDA Will Soon Give These 3 Healthcare Companies the Green Light
Motley Fool
Novavax
vaccines
COVID-19
Axsome Therapeutics
FDA
Novocure
lung cancer
Flag link:
Axsome and Aytu's Positive Day with the FDA
Axsome and Aytu's Positive Day with the FDA
BioSpace
FDA
Axsome Therapeutics
Aytu BioSciences
depression
Vascular Ehlers-Danos Syndrome
Flag link:
Axsome moves 'closer to judgement day' for stalled depression therapy
Axsome moves 'closer to judgement day' for stalled depression therapy
Fierce Biotech
Axsome Therapeutics
FDA
depression
AXS-05
Flag link:
Once heralded as its next big cash cow, Jazz takes a marked down price for not-so-hot sleep disorder drug
Once heralded as its next big cash cow, Jazz takes a marked down price for not-so-hot sleep disorder drug
Endpoints
Jazz Pharma
Sunosi
Axsome Therapeutics
Flag link:
3 Biotech Stocks That Could Rise 90% or More, According to Wall Street
3 Biotech Stocks That Could Rise 90% or More, According to Wall Street
Motley Fool
ChemoCentryx
Ocular Therapeutics
Axsome Therapeutics
Flag link:
Axsome sees depression drug decision delayed as FDA kicks expected CRL can down the road
Axsome sees depression drug decision delayed as FDA kicks expected CRL can down the road
Fierce Biotech
Axsome Therapeutics
depression
FDA
Flag link:
Could Biogen Acquire Axsome Therapeutics?
Could Biogen Acquire Axsome Therapeutics?
Motley Fool
Biogen
Axsome Therapeutics
M&A
Flag link:
Why Axsome Therapeutics Is Plunging Again Tuesday
Why Axsome Therapeutics Is Plunging Again Tuesday
Motley Fool
Axsome Therapeutics
FDA
AXS-05
Flag link:
Go or no go? August FDA decisions for Axsome, Sanofi and Merck
Go or no go? August FDA decisions for Axsome, Sanofi and Merck
EP Vantage
FDA
Axsome Therapeutics
Sanofi
Merck
Pompe disease
depression
kidney cancer
Keytruda
Flag link:
The big approvals still on the cards for 2021
The big approvals still on the cards for 2021
EP Vantage
FDA
drug approvals
Argenx
Novartis
AstraZeneca
Astellas
UCB Pharma
Ascendis Pharma
ChemoCentryx
Axsome Therapeutics
Flag link:

Pages